116 related articles for article (PubMed ID: 19092857)
1. A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.
Hoang-Le D; Smeenk L; Anraku I; Pijlman GP; Wang XJ; de Vrij J; Liu WJ; Le TT; Schroder WA; Khromykh AA; Suhrbier A
Gene Ther; 2009 Feb; 16(2):190-9. PubMed ID: 19092857
[TBL] [Abstract][Full Text] [Related]
2. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour therapeutic efficacy of OX40L in murine tumour model.
Ali SA; Ahmad M; Lynam J; McLean CS; Entwisle C; Loudon P; Choolun E; McArdle SE; Li G; Mian S; Rees RC
Vaccine; 2004 Sep; 22(27-28):3585-94. PubMed ID: 15315837
[TBL] [Abstract][Full Text] [Related]
4. Replicon-based vectors of positive strand RNA viruses.
Khromykh AA
Curr Opin Mol Ther; 2000 Oct; 2(5):555-69. PubMed ID: 11249758
[TBL] [Abstract][Full Text] [Related]
5. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.
Pan ZK; Weiskirch LM; Paterson Y
Cancer Res; 1999 Oct; 59(20):5264-9. PubMed ID: 10537307
[TBL] [Abstract][Full Text] [Related]
6. [Kunjin virus replicon--a novel viral vector].
Li S; Li X; Qin E; Qin C
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):141-6. PubMed ID: 21650037
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies.
Le TT; Gardner J; Hoang-Le D; Schmidt CW; MacDonald KP; Lambley E; Schroder WA; Ogbourne SM; Suhrbier A
Vaccine; 2009 May; 27(23):3053-62. PubMed ID: 19428919
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-tumor effect of combination radio- and immunotherapy by electro-gene therapy plus intra-tumor injection of dendritic cells.
Wang YS; Tsang YW; Chi CH; Chang CC; Chu RM; Chi KH
Cancer Lett; 2008 Aug; 266(2):275-85. PubMed ID: 18397820
[TBL] [Abstract][Full Text] [Related]
10. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors.
Collins CG; Tangney M; Larkin JO; Casey G; Whelan MC; Cashman J; Murphy J; Soden D; Vejda S; McKenna S; Kiely B; Collins JK; Barrett J; Aarons S; O'Sullivan GC
Cancer Gene Ther; 2006 Dec; 13(12):1061-71. PubMed ID: 16874363
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer.
Bubeník J
Folia Biol (Praha); 1999; 45(4):115-9. PubMed ID: 10732724
[No Abstract] [Full Text] [Related]
12. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
[TBL] [Abstract][Full Text] [Related]
13. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
15. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
Kim HA; Ko HM; Ju HW; Kim KJ; Roh SG; Lee HK; Im SY
Cancer Lett; 2009 Feb; 274(1):160-4. PubMed ID: 18952369
[TBL] [Abstract][Full Text] [Related]
16. Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models.
Forde PF; Hall LJ; de Kruijf M; Bourke MG; Doddy T; Sadadcharam M; Soden DM
Gene Ther; 2015 Jan; 22(1):29-39. PubMed ID: 25373914
[TBL] [Abstract][Full Text] [Related]
17. Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.
Pijlman GP; Suhrbier A; Khromykh AA
Expert Opin Biol Ther; 2006 Feb; 6(2):135-45. PubMed ID: 16436039
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles.
Harvey TJ; Liu WJ; Wang XJ; Linedale R; Jacobs M; Davidson A; Le TT; Anraku I; Suhrbier A; Shi PY; Khromykh AA
J Virol; 2004 Jan; 78(1):531-8. PubMed ID: 14671135
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.
Agorio C; Schreiber F; Sheppard M; Mastroeni P; Fernandez M; Martinez MA; Chabalgoity JA
J Gene Med; 2007 May; 9(5):416-23. PubMed ID: 17410612
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome.
Westermann J; Hecker AC; Flörcken A; Dörken B; Pezzutto A
J Immunother; 2009; 32(6):667-75. PubMed ID: 19483643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
